drugset / Trial / NCT05378646
Efficiency and Safety of the Drug Ingaron (Interferon-gamma Human Recombinant) in the Treatment of Chronic Prostatitis
RandomizedParallel-groupOpen-labelTreatment
Summary
The primary purposes of the study are to evaluate the effectiveness of Ingaron in the complex therapy of chronic prostatitis, to assess the safety of using Ingaron in patients with chronic prostatitis.
Timeline
- Start
- 2009-01-29
- Primary completion
- 2009-12-31
- Completion
- 2010-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | interferon gamma | Protein / enzyme biologic | 500000 iu | Subcutaneous |